NDC 51662-1602-01 - LABETALOL HCl

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51662-1602
Requested NDC: 51662-1602-01
Package NDCs from labels: 51662-1602-1, 51662-1602-9, 51662-1602-01
Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Effective date: 2022-10-01
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
LABETALOL HCl - HF Acquisition Co LLC, DBA HealthFirst	HF Acquisition Co LLC, DBA HealthFirst	2022-10-01	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51662-1602-1	LABETALOL HCl	1 in 1 BOX, UNIT-DOSE	INJECTION	1	2
51662-1602-1	LABETALOL HCl	20 mL in 1 VIAL	INJECTION	20	2
51662-1602-9	LABETALOL HCl	20 mL in 1 VIAL	INJECTION	20	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1602	LABETALOL HCL INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]	2	Current NDC, Legacy NDC, 3 package rows	20221002_e76c4b37-4a34-249d-e053-2995a90aa9be.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 5 · 84 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Hospira, Inc.	d3579d45-a964-40fe-e3a2-a3a997c8b7b9	2021-05-28	Warnings, Adverse reactions	Exact identifier unii: 1GEV3BAW9J
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Fosun Pharma USA Inc.	f18dff28-f6f5-4ecb-9797-25062e247559	2021-01-28	Warnings, Adverse reactions	Exact identifier rxcui: 896771 unii: 1GEV3BAW9J
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Baxter Healthcare Corporation	b17a7b3a-e7a5-4987-ae85-ad970e7540c7	2020-07-24	Warnings, Adverse reactions	Exact identifier rxcui: 896771 unii: 1GEV3BAW9J
Additox	TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM	BioActive Nutritional, Inc.	319ee2fe-58e3-495e-bf0d-df201f6fbb1c	2018-07-18	Warnings	Exact identifier unii: Z8IX2SC1OH unii: A2I8C7HI9T

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.